FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796345859> ?p ?o ?g. }

• W2796345859 endingPage "84" @default.
• W2796345859 startingPage "76" @default.
• W2796345859 abstract "Background. There are limited data on the efficacy of long-term enzyme replacement therapy (ERT) in children with mucopolysaccharidosis (MPS). Objective. Our aim was to study the efficacy and safety of long-term ERT in children with MPS type I, II, and VI. Methods. We analyzed the results of ERT with laronidase, idursulfase, and galsulfase in children with MPS type I, II, and VI admitted to the federal research center from January 2007 to November 2016. The response rate was assessed by the level of normalized urinary excretion of glycosaminoglycans (GAGs) (the ratio of GAGs concentration to urine creatinine) recalculated in percent (%) exceedance of the upper limit of normal for the corresponding age. Data on the administered therapy and its results, including adverse events, is extracted from the medical records of in-patients. Results. The results of treatment (intravenous infusions, intervals between administrations from 4 to 10 days) were studied in 33 children (5 of them were girls) with MPS type I (n = 4; laronidase at a dose of 0.58 mg/kg), II (n = 26; idursulfase at a dose of 0.5 mg/kg), and VI (n = 3; galsulfase at a dose of 1 mg/kg). A decrease in the normalized urinary excretion of GAGs from 376% (172; 791) to 54% (0; 146) exceedance of the upper limit of normal for the age (p < 0.001) was noted in the course of ERT lasting (median) 27 (14; 41) months. A decrease in the normalized GAGs excretion below the upper limit of normal for the age was established in 12/33 (36%) patients. ERT-associated adverse events were identified in 12 patients; one case required a two-fold therapy interruption. The development of nephrotic syndrome in the course of ERT in patients with severe MPS II was first described. Conclusion. Long-term ERT in children with MPS type I, II, and VI is characterized by acceptable efficacy and safety. Key words: children, mucopolysaccharidosis, enzyme replacement therapy, laronidase, idursulfase, galsulfase, glycosaminoglycans." @default.
• W2796345859 created "2018-04-13" @default.
• W2796345859 creator A5016910904 @default.
• W2796345859 creator A5027783305 @default.
• W2796345859 creator A5040473613 @default.
• W2796345859 creator A5054185538 @default.
• W2796345859 creator A5060647928 @default.
• W2796345859 creator A5068204891 @default.
• W2796345859 creator A5084218806 @default.
• W2796345859 creator A5088740796 @default.
• W2796345859 date "2018-04-01" @default.
• W2796345859 modified "2023-10-14" @default.
• W2796345859 title "EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY" @default.
• W2796345859 doi "https://doi.org/10.15690/vsp.v17i1.1858" @default.
• W2796345859 hasPublicationYear "2018" @default.
• W2796345859 type Work @default.
• W2796345859 sameAs 2796345859 @default.
• W2796345859 citedByCount "1" @default.
• W2796345859 countsByYear W27963458592018 @default.
• W2796345859 crossrefType "journal-article" @default.
• W2796345859 hasAuthorship W2796345859A5016910904 @default.
• W2796345859 hasAuthorship W2796345859A5027783305 @default.
• W2796345859 hasAuthorship W2796345859A5040473613 @default.
• W2796345859 hasAuthorship W2796345859A5054185538 @default.
• W2796345859 hasAuthorship W2796345859A5060647928 @default.
• W2796345859 hasAuthorship W2796345859A5068204891 @default.
• W2796345859 hasAuthorship W2796345859A5084218806 @default.
• W2796345859 hasAuthorship W2796345859A5088740796 @default.
• W2796345859 hasBestOaLocation W27963458591 @default.
• W2796345859 hasConcept C10146269 @default.
• W2796345859 hasConcept C126322002 @default.
• W2796345859 hasConcept C126894567 @default.
• W2796345859 hasConcept C187212893 @default.
• W2796345859 hasConcept C197934379 @default.
• W2796345859 hasConcept C2779134260 @default.
• W2796345859 hasConcept C2779416428 @default.
• W2796345859 hasConcept C2779969927 @default.
• W2796345859 hasConcept C2780026642 @default.
• W2796345859 hasConcept C2780306776 @default.
• W2796345859 hasConcept C2910638406 @default.
• W2796345859 hasConcept C71924100 @default.
• W2796345859 hasConcept C72563966 @default.
• W2796345859 hasConcept C77411442 @default.
• W2796345859 hasConceptScore W2796345859C10146269 @default.
• W2796345859 hasConceptScore W2796345859C126322002 @default.
• W2796345859 hasConceptScore W2796345859C126894567 @default.
• W2796345859 hasConceptScore W2796345859C187212893 @default.
• W2796345859 hasConceptScore W2796345859C197934379 @default.
• W2796345859 hasConceptScore W2796345859C2779134260 @default.
• W2796345859 hasConceptScore W2796345859C2779416428 @default.
• W2796345859 hasConceptScore W2796345859C2779969927 @default.
• W2796345859 hasConceptScore W2796345859C2780026642 @default.
• W2796345859 hasConceptScore W2796345859C2780306776 @default.
• W2796345859 hasConceptScore W2796345859C2910638406 @default.
• W2796345859 hasConceptScore W2796345859C71924100 @default.
• W2796345859 hasConceptScore W2796345859C72563966 @default.
• W2796345859 hasConceptScore W2796345859C77411442 @default.
• W2796345859 hasIssue "1" @default.
• W2796345859 hasLocation W27963458591 @default.
• W2796345859 hasLocation W27963458592 @default.
• W2796345859 hasOpenAccess W2796345859 @default.
• W2796345859 hasPrimaryLocation W27963458591 @default.
• W2796345859 hasRelatedWork W1584581471 @default.
• W2796345859 hasRelatedWork W2033959986 @default.
• W2796345859 hasRelatedWork W2042480476 @default.
• W2796345859 hasRelatedWork W2068499319 @default.
• W2796345859 hasRelatedWork W2369552721 @default.
• W2796345859 hasRelatedWork W247452021 @default.
• W2796345859 hasRelatedWork W3039642561 @default.
• W2796345859 hasRelatedWork W3082276934 @default.
• W2796345859 hasRelatedWork W3205723446 @default.
• W2796345859 hasRelatedWork W4200201926 @default.
• W2796345859 hasVolume "17" @default.
• W2796345859 isParatext "false" @default.
• W2796345859 isRetracted "false" @default.
• W2796345859 magId "2796345859" @default.
• W2796345859 workType "article" @default.